2014-09-03 21:40:32 UTC

CGH Podcast September 2014: Restarting Infliximab in IBD Patients with Prior Loss of Response

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks to an author of the editorial, Dr. Maria T. Abreu of the University of the Miami Miller School of Medicine, Miami, Florida; Plus, summaries of top stories from this month's issue of GI and Hepatology News.

 

 

Yarur AJ, Abreu MT. Back to the Beginning: Restarting Infliximab in Inflammatory Bowel Disease Patients With Prior Loss of Response. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1482-1484
Full Text

 

 

Related article:
Baert F, Drobne D, Gils A, et al. Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1474-1481
Abstract

 

 

Duration: 17.32m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

 

 

More on IBD

Unmasking the Origins of IBD

June 14, 2018

Call for studies on biological and environmental factors driving differences between ethnicities and between immigrants versus non-immigrants

U.S. Cities Consider Supervised Injection Sites

May 31, 2018

Safe injection facilities can reduce overdoses, disease transmission, and public drug use

IBD: Exercise May Reduce Risk and Improve Symptoms

May 17, 2018

Data needed to clarify specific activity regimens for individual patients